Status:
ACTIVE_NOT_RECRUITING
Nutrition and Inflammation in Patients with Head and Neck Cancer
Lead Sponsor:
Uppsala University
Collaborating Sponsors:
Swedish Cancer Society
The Kamprad Family Foundation for Entrepreneurship, Research & Charity
Conditions:
Head and Neck Neoplasms
Radiotherapy Side Effect
Eligibility:
All Genders
18+ years
Brief Summary
An estimated 1500 people in Sweden will annually be diagnosed with head and neck cancer (HNC). Five year survival is approximately 69%. Long-term sequelae are common and in particular nutritional prob...
Detailed Description
The incidence of head and neck cancer (HNC) has increased in Sweden during the last decades. Radiotherapy (RT) is a cornerstone of treatment either as single or combined modality treatment. There is e...
Eligibility Criteria
Inclusion
- Patients with newly diagnosed head and neck cancer
Exclusion
- Previous treatment for malignant disease except for skin cancer, severe alcohol abuse, psychiatric disorder, inability to understand Swedish
Key Trial Info
Start Date :
November 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2027
Estimated Enrollment :
522 Patients enrolled
Trial Details
Trial ID
NCT03343236
Start Date
November 1 2015
End Date
December 31 2027
Last Update
December 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Otolaryngology, Head & Neck Surgery, Uppsala University Hospital
Uppsala, Sweden, SE-75185